Gyre Therapeutics (GYRE) announced Han Ying has stepped down as CEO and will transition into the role of senior VP, science and will oversee research and discovery activities to support Gyre’s fibrosis focused pipeline. Ping Zhang, executive chairman, has been appointed interim CEO, and will lead the company’s day-to-day operations and strategic global expansion.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GYRE: